These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 11290810)

  • 1. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.
    Bonini C; Lee SP; Riddell SR; Greenberg PD
    J Immunol; 2001 Apr; 166(8):5250-7. PubMed ID: 11290810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responses.
    Muraro S; Bondanza A; Bellone M; Greenberg PD; Bonini C
    Blood; 2005 May; 105(9):3596-604. PubMed ID: 15650058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells.
    Nagorsen D; Panelli M; Dudley ME; Finkelstein SE; Rosenberg SA; Marincola FM
    Gene Ther; 2003 Sep; 10(20):1754-65. PubMed ID: 12939642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
    Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
    J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
    Pooley JL; Heath WR; Shortman K
    J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Kang TH; Lee JH; Bae HC; Noh KH; Kim JH; Song CK; Shin BC; Hung CF; Wu TC; Park JS; Kim TW
    Immunol Lett; 2006 Aug; 106(2):126-34. PubMed ID: 16844231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals.
    Granelli-Piperno A; Zhong L; Haslett P; Jacobson J; Steinman RM
    J Immunol; 2000 Dec; 165(11):6620-6. PubMed ID: 11086107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen gene transfer to human plasmacytoid dendritic cells using recombinant adenovirus and vaccinia virus vectors.
    Bontkes HJ; Ruizendaal JJ; Schreurs MW; Kramer D; Meijer CJ; Hooijberg E
    Cell Oncol; 2005; 27(3):175-82. PubMed ID: 16037638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
    Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response.
    Weissman D; Ni H; Scales D; Dude A; Capodici J; McGibney K; Abdool A; Isaacs SN; Cannon G; Karikó K
    J Immunol; 2000 Oct; 165(8):4710-7. PubMed ID: 11035115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.
    Loré K; Adams WC; Havenga MJ; Precopio ML; Holterman L; Goudsmit J; Koup RA
    J Immunol; 2007 Aug; 179(3):1721-9. PubMed ID: 17641038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines.
    Kohrgruber N; Halanek N; Gröger M; Winter D; Rappersberger K; Schmitt-Egenolf M; Stingl G; Maurer D
    J Immunol; 1999 Sep; 163(6):3250-9. PubMed ID: 10477594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
    Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
    J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
    Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
    EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.
    Kreiter S; Selmi A; Diken M; Sebastian M; Osterloh P; Schild H; Huber C; Türeci O; Sahin U
    J Immunol; 2008 Jan; 180(1):309-18. PubMed ID: 18097032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
    Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
    J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.